-
Je něco špatně v tomto záznamu ?
HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells
M. Kučírek, AJ. Bagherpoor, J. Jaroš, A. Hampl, M. Štros,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-31501A
MZ0
CEP - Centrální evidence projektů
PubMed
31661640
DOI
10.1096/fj.201901465rrr
Knihovny.cz E-zdroje
- MeSH
- buněčná diferenciace MeSH
- genetická transkripce MeSH
- kmenové buňky cytologie enzymologie MeSH
- lidé MeSH
- lidské embryonální kmenové buňky cytologie enzymologie MeSH
- protein HMGB1 genetika MeSH
- protein HMGB2 genetika fyziologie MeSH
- telomerasa metabolismus MeSH
- transfekce MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-3β/β-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA+ transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.-Kučírek, M., Bagherpoor, A. J., Jaroš, J., Hampl, A., Štros, M. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023386
- 003
- CZ-PrNML
- 005
- 20201214125913.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1096/fj.201901465RRR $2 doi
- 035 __
- $a (PubMed)31661640
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kučírek, Martin $u Laboratory of Analysis of Chromosomal Proteins, Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
- 245 10
- $a HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells / $c M. Kučírek, AJ. Bagherpoor, J. Jaroš, A. Hampl, M. Štros,
- 520 9_
- $a High-mobility group box (HMGB)1 and HMGB2 proteins are the subject of intensive research because of their involvement in DNA replication, repair, transcription, differentiation, proliferation, cell signaling, inflammation, and tumor migration. Using inducible, stably transfected human embryonic stem cells (hESCs) capable of the short hairpin RNA-mediated knockdown (KD) of HMGB1 and HMGB2, we provide evidence that deregulation of HMGB1 or HMGB2 expression in hESCs and their differentiated derivatives (neuroectodermal cells) results in distinct modulation of telomere homeostasis. Whereas HMGB1 enhances telomerase activity, HMGB2 acts as a negative regulator of telomerase activity in the cell. Stimulation of telomerase activity in the HMGB2-deficient cells may be related to activation of the PI3K/protein kinase B/ glycogen synthase kinase-3β/β-catenin signaling pathways by HMGB1, augmented TERT/telomerase RNA subunit transcription, and possibly also because of changes in telomeric repeat-containing RNA (TERRA) and TERRA-polyA+ transcription. The impact of HMGB1/2 KD on telomerase transcriptional regulation observed in neuroectodermal cells is partially masked in hESCs by their pluripotent state. Our findings on differential roles of HMGB1 and HMGB2 proteins in regulation of telomerase activity may suggest another possible outcome of HMGB1 targeting in cells, which is currently a promising approach aiming at increasing the anticancer activity of cytotoxic agents.-Kučírek, M., Bagherpoor, A. J., Jaroš, J., Hampl, A., Štros, M. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells.
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a protein HMGB1 $x genetika $7 D024243
- 650 _2
- $a protein HMGB2 $x genetika $x fyziologie $7 D024261
- 650 _2
- $a lidské embryonální kmenové buňky $x cytologie $x enzymologie $7 D000066449
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kmenové buňky $x cytologie $x enzymologie $7 D013234
- 650 _2
- $a telomerasa $x metabolismus $7 D019098
- 650 _2
- $a genetická transkripce $7 D014158
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bagherpoor, Alireza J $u Laboratory of Analysis of Chromosomal Proteins, Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Jaroš, Josef $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cell and Tissue Regeneration, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Hampl, Aleš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Cell and Tissue Regeneration, International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic.
- 700 1_
- $a Štros, Michal $u Laboratory of Analysis of Chromosomal Proteins, Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
- 773 0_
- $w MED00001782 $t FASEB journal : official publication of the Federation of American Societies for Experimental Biology $x 1530-6860 $g Roč. 33, č. 12 (2019), s. 14307-14324
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31661640 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125912 $b ABA008
- 999 __
- $a ok $b bmc $g 1595705 $s 1114062
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 33 $c 12 $d 14307-14324 $e 20191026 $i 1530-6860 $m The FASEB journal $n FASEB J $x MED00001782
- GRA __
- $a NV16-31501A $p MZ0
- LZP __
- $a Pubmed-20201125